简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-10-10 13:28 Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
2023-10-08 16:09 Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease
2023-10-08 14:13 Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
2023-10-08 10:34 RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
2023-10-07 16:11 Takeda Provides Update on EXKIVITY® (mobocertinib)
2023-10-07 12:17 TDCX Grows in Europe With Two New Healthtech Clients
2023-10-07 11:52 The Estée Lauder Companies Launches 2023 Breast Cancer Campaign: Beautifully United to Help End Breast Cancer
2023-10-07 10:50 EADV 2023: Galderma to Present New Data Showcasing Its Continued Leadership in Dermatology
2023-10-07 10:45 Galderma announces progress with RelabotulinumtoxinA regulatory submissions
2023-10-07 10:43 Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
2023-09-27 16:11 Korean Unicorn APR Files for Preliminary IPO Review on KRX
2023-09-27 09:00 Medisca Takes Steps to Protect its Innovative Technologies
2023-09-27 08:28 Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia
2023-09-26 17:58 Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
2023-09-25 18:51 Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award
2023-09-25 11:15 Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
2023-09-22 10:29 ReNAgade Therapeutics Named to the 2023 Endpoints 11
2023-09-21 08:47 MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
2023-09-20 15:35 Julie Gerardi Joins Parse Biosciences as Vice President of Business Development
2023-09-20 15:06 Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera Published in Medical Journal Leukemia

Business Wire Weibo

Press Releases

Latest Releases